Class II
Drug Recall: Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Medisca Inc. · June 26, 2024
Reason for Recall
CGMP Deviations and Presence of Particulate Matter: Glass
Distribution
Nationwide in the USA and Canada
States Affected
NATIONWIDE
Quantity Affected
113 bottles
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0570-2024
Status: completed
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.